RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ampio Pharmaceuticals Stock

Ampio Pharmaceuticals P/E 2024

Ampio Pharmaceuticals P/E

-1.22

Ticker

AMPE

ISIN

US03209T1097

WKN

A1JGFU

As of Dec 19, 2024, Ampio Pharmaceuticals's P/E ratio was -1.22, a 134.62% change from the -0.52 P/E ratio recorded in the previous year.

The Ampio Pharmaceuticals P/E history

Ampio Pharmaceuticals Aktienanalyse

What does Ampio Pharmaceuticals do?

Ampio Pharmaceuticals Inc is a biopharmaceutical company specialized in developing and marketing novel therapies for various diseases. The company was founded in 2010 and is headquartered in Englewood, Colorado. The history of Ampio Pharmaceuticals began with a goal: to realize the vision of developing innovative therapies that benefit patients. The founding idea focused on the development of a new therapy for osteoarthritis. Over time, however, the company diversified and specialized in the development of drugs for other areas such as diabetes, eye diseases, and pneumonia. Ampio Pharmaceuticals' business model is focused on cutting-edge technologies and scientific knowledge. The company employs an integrative approach that utilizes a variety of techniques, including cell-based therapies, gene therapies, and drug development. The company's core competencies lie in research, development, and marketing of innovative therapy options. Ampio Pharmaceuticals is divided into various business units. For example, the company is engaged in the development of drugs based on AMPio technologies. These compounds form the core of the therapy approaches and have already shown promising results in clinical trials. The company also emphasizes collaboration with partners to expedite the development of new therapy options. Another focus of Ampio Pharmaceuticals is the development of therapies for osteoarthritis. The company has developed a range of therapeutics targeting various aspects of the disease, such as anti-inflammatory agents and substances for joint cartilage regeneration. These therapies aim to alleviate the symptoms of osteoarthritis and provide patients with a higher quality of life. In addition to developing new therapy options, Ampio Pharmaceuticals also conducts clinical trials. These studies are designed to test the efficacy and safety of the developed drugs. Ampio Pharmaceuticals is committed to providing the highest standard of medical care by substantiating the safety and efficacy of their drugs through clinical trials. As a company specialized in drug development, Ampio Pharmaceuticals has launched a number of products on the market. These include Ampion, an injectable therapy for knee osteoarthritis, and Optina, an orally administered drug for the treatment of diabetes-related retinopathy. Overall, Ampio Pharmaceuticals is an innovative company specializing in the development of new therapy options. The company leverages modern technologies and scientific knowledge and aims to improve patients' lives through highly effective therapies. Ampio Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Ampio Pharmaceuticals's P/E Ratio

The Price to Earnings (P/E) Ratio of Ampio Pharmaceuticals is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Ampio Pharmaceuticals's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Ampio Pharmaceuticals is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Ampio Pharmaceuticals’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Ampio Pharmaceuticals stock

What is the price-to-earnings ratio of Ampio Pharmaceuticals?

The price-earnings ratio of Ampio Pharmaceuticals is currently -1.22.

How has the price-earnings ratio of Ampio Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Ampio Pharmaceuticals has increased by 134.62% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Ampio Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Ampio Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Ampio Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Ampio Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Ampio Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Ampio Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Ampio Pharmaceuticals?

Some factors that influence the price-earnings ratio of Ampio Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Ampio Pharmaceuticals pay?

Over the past 12 months, Ampio Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ampio Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Ampio Pharmaceuticals?

The current dividend yield of Ampio Pharmaceuticals is .

When does Ampio Pharmaceuticals pay dividends?

Ampio Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ampio Pharmaceuticals?

Ampio Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Ampio Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ampio Pharmaceuticals located?

Ampio Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ampio Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ampio Pharmaceuticals from 12/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did Ampio Pharmaceuticals pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of Ampio Pharmaceuticals in the year 2023?

In the year 2023, Ampio Pharmaceuticals distributed 0 USD as dividends.

In which currency does Ampio Pharmaceuticals pay out the dividend?

The dividends of Ampio Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ampio Pharmaceuticals

Our stock analysis for Ampio Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ampio Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.